These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19326580)

  • 21. The JBS-2 guidelines on prevention of cardiovascular disease in clinical practice: an opportunity missed.
    Jessani S; Lip GY; Barnett A; Millane T
    QJM; 2007 Feb; 100(2):121-4. PubMed ID: 17277318
    [No Abstract]   [Full Text] [Related]  

  • 22. [Blood glucose quickly under control in diabetes mellitus 2].
    Wentholt IM; de Vries JH; Holleman F; Hoekstra JB
    Ned Tijdschr Geneeskd; 2009 Feb; 153(9):376-7. PubMed ID: 19348090
    [No Abstract]   [Full Text] [Related]  

  • 23. Diabetes quiz. How much do you know about heart attacks?
    Dinsmoor RS
    Diabetes Self Manag; 2006; 23(5):86, 88. PubMed ID: 17022132
    [No Abstract]   [Full Text] [Related]  

  • 24. Vascular protection with fibroblast growth factor 21 in diabetes: its potential beyond glucose and lipid control.
    Liu MH
    Int J Cardiol; 2015 Nov; 199():403-4. PubMed ID: 26253049
    [No Abstract]   [Full Text] [Related]  

  • 25. [Behavior of the glycoproteins in the blood serum in diabetes mellitus].
    Laskowski S
    Przegl Lek; 1966; 22(8):521-5. PubMed ID: 5954884
    [No Abstract]   [Full Text] [Related]  

  • 26. Glucose control, macro- and microvascular disease, and the Food and Drug Administration: let's keep our eye on the ball.
    Kahn SE; Cefalu WT
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3727-9. PubMed ID: 18765506
    [No Abstract]   [Full Text] [Related]  

  • 27. [Content of PAS-positive substances in the lymphocytes in diabetes mellitus and angiopathies].
    Lapko LI; Gruzov MA
    Vrach Delo; 1980 Apr; (4):83-5. PubMed ID: 7385781
    [No Abstract]   [Full Text] [Related]  

  • 28. Shifting the disease management paradigm from glucose: what are the cons?
    Hanefeld M; Bornstein SR; Pistrosch F
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S353-6. PubMed ID: 19875580
    [No Abstract]   [Full Text] [Related]  

  • 29. Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction.
    Goyal A; Mehta SR; Gerstein HC; Díaz R; Afzal R; Xavier D; Zhu J; Pais P; Lisheng L; Kazmi KA; Zubaid M; Piegas LS; Widimsky P; Budaj A; Avezum A; Yusuf S
    Am Heart J; 2009 Apr; 157(4):763-70. PubMed ID: 19332208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [2,3-DPG and diabetic microangiopathy].
    Faure Nogueras E; Millastre Benito A; Blasco Comenge MC; García Alvarez F; Gutiérrez Martín M
    Rev Clin Esp; 1981 Nov; 163(4):227-30. PubMed ID: 7335930
    [No Abstract]   [Full Text] [Related]  

  • 31. [Tryptophan and 5-hydroxytryptamine (serotonin) content of the blood of patients with diabetes mellitus].
    Bondar PN; Kokoshchuk GI
    Vrach Delo; 1974 Mar; (3):49-51. PubMed ID: 4468665
    [No Abstract]   [Full Text] [Related]  

  • 32. Myocardial infarction and hyperglycemia.
    Marfella R; Verza M; Coppola L
    Am J Cardiol; 2005 Nov; 96(10):1468. PubMed ID: 16275205
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of blood glucose values on admission for acute myocardial infarction in patients with versus without diabetes mellitus.
    Ishihara M; Kojima S; Sakamoto T; Kimura K; Kosuge M; Asada Y; Tei C; Miyazaki S; Sonoda M; Tsuchihashi K; Yamagishi M; Shirai M; Hiraoka H; Honda T; Ogata Y; Ogawa H;
    Am J Cardiol; 2009 Sep; 104(6):769-74. PubMed ID: 19733709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diabetics in secondary prevention].
    Tschöpe D
    Clin Res Cardiol; 2006; 95 Suppl 6():VI23-7. PubMed ID: 17013581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microvascular complications of diabetes mellitus and glycemic control.
    Sheffield MV
    Ann Intern Med; 1987 Apr; 106(4):638-9. PubMed ID: 3548528
    [No Abstract]   [Full Text] [Related]  

  • 36. [Proceedings: Dynamics of growth hormone in the blood in diabetic patients, with special reference to its relationship to microangiopathy].
    Yoshida K; Hayakawa H; Takasakura E; Kawai K; Muramoto S
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):208. PubMed ID: 4476348
    [No Abstract]   [Full Text] [Related]  

  • 37. [Behavior of 2,3-diphosphoglycerate in diabetes mellitus].
    Rodríguez Cuartero A; Rodríguez Cuartero F; Pérez Blanco F; Núñez Carril J; Mora Lara RJ
    Rev Clin Esp; 1982 Apr; 165(1):39-41. PubMed ID: 6812175
    [No Abstract]   [Full Text] [Related]  

  • 38. Platelets and diabetes mellitus.
    Mustand JF; Packham MA
    N Engl J Med; 1984 Sep; 311(10):665-7. PubMed ID: 6472345
    [No Abstract]   [Full Text] [Related]  

  • 39. [Fibronectin and diabetes mellitus].
    Skrha J
    Cas Lek Cesk; 1988 Apr; 127(17):516-9. PubMed ID: 3396032
    [No Abstract]   [Full Text] [Related]  

  • 40. Type 1 diabetes mellitus following acute myocardial infarction in a young adult.
    Kahara T; Nagata Y; Akahori H; Usuda R
    Intern Med; 2005 Aug; 44(8):897-8. PubMed ID: 16157996
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.